Clinical and cardiac characteristics of COVID-19 mortalities in a diverse New York City Cohort.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
12 2020
Historique:
received: 02 06 2020
revised: 14 08 2020
accepted: 22 09 2020
pubmed: 7 10 2020
medline: 7 1 2021
entrez: 6 10 2020
Statut: ppublish

Résumé

Electrocardiographic characteristics in COVID-19-related mortality have not yet been reported, particularly in racial/ethnic minorities. We reviewed demographics, laboratory and cardiac tests, medications, and cardiac rhythm proximate to death or initiation of comfort care for patients hospitalized with a positive SARS-CoV-2 reverse-transcriptase polymerase chain reaction in three New York City hospitals between March 1 and April 3, 2020 who died. We described clinical characteristics and compared factors contributing toward arrhythmic versus nonarrhythmic death. Of 1258 patients screened, 133 died and were enrolled. Of these, 55.6% (74/133) were male, 69.9% (93/133) were racial/ethnic minorities, and 88.0% (117/133) had cardiovascular disease. The last cardiac rhythm recorded was VT or fibrillation in 5.3% (7/133), pulseless electrical activity in 7.5% (10/133), unspecified bradycardia in 0.8% (1/133), and asystole in 26.3% (35/133). Most 74.4% (99/133) died receiving comfort measures only. The most common abnormalities on admission electrocardiogram included abnormal QRS axis (25.8%), atrial fibrillation/flutter (14.3%), atrial ectopy (12.0%), and right bundle branch block (11.9%). During hospitalization, an additional 17.6% developed atrial ectopy, 14.7% ventricular ectopy, 10.1% atrial fibrillation/flutter, and 7.8% a right ventricular abnormality. Arrhythmic death was confirmed or suspected in 8.3% (11/133) associated with age, coronary artery disease, asthma, vasopressor use, longer admission corrected QT interval, and left bundle branch block (LBBB). Conduction, rhythm, and electrocardiographic abnormalities were common during COVID-19-related hospitalization. Arrhythmic death was associated with age, coronary artery disease, asthma, longer admission corrected QT interval, LBBB, ventricular ectopy, and usage of vasopressors. Most died receiving comfort measures.

Identifiants

pubmed: 33022765
doi: 10.1111/jce.14772
pmc: PMC7675758
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

3086-3096

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

J Am Coll Cardiol. 2012 Dec 4;60(22):2263-70
pubmed: 23194937
J Crit Care. 2015 Oct;30(5):994-7
pubmed: 26138630
Crit Pathw Cardiol. 2020 Sep;19(3):105-111
pubmed: 32324622
Circ Arrhythm Electrophysiol. 2020 Jun;13(6):e008662
pubmed: 32347743
N Engl J Med. 2020 Mar 5;382(10):929-936
pubmed: 32004427
JAMA Netw Open. 2020 Apr 24;3(4):e208857
pubmed: 32330277
Ann Pharmacother. 1995 Mar;29(3):269-81
pubmed: 7606074
J Cardiovasc Electrophysiol. 2020 Dec;31(12):3086-3096
pubmed: 33022765
JAMA. 2020 Jun 2;323(21):2192-2195
pubmed: 32347898
Heart Rhythm. 2011 Feb;8(2):271-7
pubmed: 21044898
N Engl J Med. 2020 Jun 18;382(25):2411-2418
pubmed: 32379955
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973
pubmed: 32311448
Front Physiol. 2019 Jan 07;9:1847
pubmed: 30666210
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Front Public Health. 2020 Apr 29;8:152
pubmed: 32411652
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
JAMA Cardiol. 2020 Jul 1;5(7):811-818
pubmed: 32219356
Mayo Clin Proc. 2020 Jun;95(6):1213-1221
pubmed: 32359771
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
N Engl J Med. 2020 Jun 11;382(24):2372-2374
pubmed: 32302078
J Am Coll Cardiol. 2015 Jul 14;66(2):101-9
pubmed: 26160626
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
J Am Coll Cardiol. 2020 May 12;75(18):2352-2371
pubmed: 32201335
J Thorac Dis. 2018 May;10(5):3081-3087
pubmed: 29997977
JAMA. 2020 Jun 23;323(24):2493-2502
pubmed: 32392282
Arch Intern Med. 2004 May 10;164(9):943-8
pubmed: 15136301
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Circ Arrhythm Electrophysiol. 2017 Oct;10(10):
pubmed: 29030380
BMJ. 2020 Apr 20;369:m1548
pubmed: 32312785
Heart Rhythm. 2020 Sep;17(9):1487-1492
pubmed: 32380288
Resuscitation. 2020 Jun;151:18-23
pubmed: 32283117
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143

Auteurs

Mark P Abrams (MP)

Department of Medicine, Division of Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York, New York, USA.

Elaine Y Wan (EY)

Department of Medicine, Division of Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York, New York, USA.

Marc P Waase (MP)

Department of Medicine, Division of Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York, New York, USA.

John P Morrow (JP)

Department of Medicine, Division of Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York, New York, USA.

Jose M Dizon (JM)

Department of Medicine, Division of Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York, New York, USA.

Hirad Yarmohammadi (H)

Department of Medicine, Division of Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York, New York, USA.

Jeremy P Berman (JP)

Department of Medicine, Division of Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York, New York, USA.

Geoffrey A Rubin (GA)

Department of Medicine, Division of Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York, New York, USA.

Alexander Kushnir (A)

Department of Medicine, Division of Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York, New York, USA.

Timothy J Poterucha (TJ)

Department of Medicine, Division of Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York, New York, USA.

Pierre A Elias (PA)

Department of Medicine, Division of Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York, New York, USA.

David A Rubin (DA)

Department of Medicine, Division of Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York, New York, USA.

Frederick Ehlert (F)

Department of Medicine, Division of Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York, New York, USA.

Angelo Biviano (A)

Department of Medicine, Division of Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York, New York, USA.

Nir Uriel (N)

Department of Medicine, Division of Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York, New York, USA.

Hasan Garan (H)

Department of Medicine, Division of Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York, New York, USA.

Deepak Saluja (D)

Department of Medicine, Division of Cardiology, New York-Presbyterian Hospital-Columbia University Irving Medical Center, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH